3 tips for biotech startups seeking non-dilutive capital to survive the downturn – TechCrunch
James Coates is the Health and Human Performance principal at Decisive Point, a venture capital and advisory firm that invests in and supports startups with emerging defense technologies. Future-proofing the finances of your biotech startup through a market collapse means more than just raising capital or rushing to close your round. I perform due diligence…